<DOC>
	<DOCNO>NCT00595257</DOCNO>
	<brief_summary>The purpose study determine concentrate nucleated cell bone marrow , inject infused ischemic limb , restore sufficient blood flow avoid amputation .</brief_summary>
	<brief_title>Feasability Study Autologous Bone Marrow Aspirate Concentrate Treatment CLI</brief_title>
	<detailed_description />
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>1 . Diagnosis Critical Limb Ischemia per protocol ( see diagnostic criterion # 2 ) regard study limb . Existence PAOD clinical presentation correspond Rutherford Category 4 Category 5 define reporting standard adopt Society Vascular Surgeons ( table 1 ) 2 . Patient meet least one follow diagnostic criterion study limb : Ankle artery occlusion pressure absolute &lt; 50 mmHg ABI &lt; 0.4 Toe artery occlusive pressure &lt; 40mm Hg TBI ( &lt; 0.4 ) TcPO2 &lt; 20 mmHg lie breathing room air , available . 3 . There reasonable open surgical endovascular revascularization option determine treat vascular specialist . Factors may contribute determination inoperability may include : Anatomical consideration No outflow target No appropriate conduit ( i.e . vein bypass ) Long segment occlusion calcify lesion predict poor outcome endovascular approach . High risk medical condition Unstable cardiac disease . Renal insufficiency History prior fail revascularization attempt The patient 's unsuitability must confirm 2 qualified physician . The attend vascular surgeon provide primary assessment . The confirmatory opinion must come fully license physician . ( resident ) If anatomical consideration invoke , second physician may vascular surgeon , interventional radiologist , cardiologist , vascular medicine specialist . If medical comorbidity deem high risk aspect , confirmatory opinion may obtain internist , family physician , cardiologist , vascular medicine , nephrologists , vascular surgeon . 4 . Age &gt; 18 year ability understand plan treatment 5 . Subject read sign IRB/IEC approve Informed Consent form 6 . Patients follow medication ( ) prescribe must one month stable baseline appropriate/maximally tolerate therapy prior enrollment : Plavix/asprin therapy , anticoagulation therapy , cholesterol lower agent , blood pressure medication 7 . Hematocrit ≥ 28.0 % , White Blood Cell count ≤ 14,000 , Platelet count ≥ 50,000 , INR ≤ 1.6 unless Coumadin , PTT &lt; 1.5 x control ( avoid bleeding complication ) Patients Coumadin correct prior procedure must INR &lt; 1.6 time randomization/surgery . 1 . Life expectancy &lt; 6 month due concomitant illnesses 2 . History bone marrow disease ( especially NHL , MDS ) prohibit transplantation 3 . Terminal renal failure exist dependence dialysis 4 . Known active malignancy result outside normal limit follow test : PAP , Chest Xray , PSA , Mammogram , Hemocult unless followup study reveal patient cancer free.. 5 . Poorly control diabetes mellitus ( HgbA1C &gt; 10 % ) 6 . Medical risk precludes anesthesia ( conscious sedation ) , ASA Class 5 7 . Lifethreatening complication ischemia necessitate immediate amputation 8 . Uncorrected iliac artery occlusion index side 9 . Extensive necrosis index limb condition make amputation inevitable ( Rutherford Category 6 ) 10 . Active clinical infection treat antibiotic within one week enrollment 11 . Treatment immunosuppressant drug ( include Prednisone &gt; 5 mg per day ) . 12 . Female pregnant nursing , child bear potential use reliable birth control method . 13 . Underwent major cardiovascular surgical procedure ( carotid endarterectomy , open arterial aneurysm bypass surgery , coronary artery bypass surgery ) adverse cardiovascular event ( stroke MI ) within 30 day prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>PAD , CLI , Critical Limb Ischemia , bone marrow , stem cell , injection , infusion</keyword>
</DOC>